Janux Therapeutics Inc (JANX) earnings · rev $10.0M
These earnings events as JSON? API free 100/dayJanux Therapeutics Inc (JANX) is a biotechnology company listed on US.
This JANX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported JANX revenue for 2025-12-31 was $10.0M. Net income was -$113.6M. Revenue was down 5.6% from 2024-12-31 to 2025-12-31. JANX currently screens at market cap $1.49B.
When the next JANX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 5.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full JANX research stays on the stock page; the tape stays on the quote page.
JANX earnings FAQ
What are JANX's latest revenue and net income?
Latest cached Janux Therapeutics Inc (JANX) revenue for Dec 31, 2025 was $10.0M. Net income was -$113.6M. Statements: https://lician.com/financials/janx
What is JANX's latest diluted EPS?
Latest cached Janux Therapeutics Inc (JANX) diluted EPS for Dec 31, 2025 was -$1.83.
What period does the latest JANX earnings print cover?
The latest cached Janux Therapeutics Inc (JANX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did JANX revenue change from the prior cached period?
Cached Janux Therapeutics Inc (JANX) revenue was down 5.6% from $10.6M (Dec 31, 2024) to $10.0M (Dec 31, 2025). Statements: https://lician.com/financials/janx
Where are JANX earnings listed?
Cached earnings facts for Janux Therapeutics Inc (JANX) are listed at https://lician.com/earnings/janx. Statements: https://lician.com/financials/janx
Not investment advice.